Berger Mark Stanley has filed 7 insider transactions across 1 company since February 2023.
Most recent transaction: a tax payment of 7168 shares of Genprex, Inc. ($GNPX) on February 27, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Genprex, Inc. | $GNPX | Berger Mark Stanley | Chief Medical Officer | F | Common Stock | 7168 | $2.00 | 21,692.0000 | 2,270,346 | 24.84% | 0.32% |
| Dec. 22, 2025 | Genprex, Inc. | $GNPX | Berger Mark Stanley | Chief Medical Officer | A | Common Stock | 28500 | $0.00 | 28,860.0000 | 2,270,346 | 7916.67% | 1.26% |
| June 30, 2025 | Genprex, Inc. | $GNPX | Berger Mark Stanley | Chief Medical Officer | F | Common Stock | 4500 | $0.23 | 17,971.0000 | 24,152,848 | 20.03% | 0.02% |
| Feb. 18, 2025 | Genprex, Inc. | $GNPX | Berger Mark Stanley | Chief Medical Officer | F | Common Stock | 585 | $0.41 | 22,471.0000 | 0 | 2.54% | 0.00% |
| Dec. 5, 2024 | Genprex, Inc. | $GNPX | Berger Mark Stanley | Chief Medical Officer | A | Common Stock | 18250 | $0.00 | 23,056.0000 | 0 | 379.73% | 0.00% |
| Feb. 18, 2024 | Genprex, Inc. | $GNPX | Berger Mark Stanley | Chief Medical Officer | F | Common Stock | 1319 | $4.40 | 4,806.0000 | 0 | 21.53% | 0.00% |
| Feb. 18, 2023 | Genprex, Inc. | $GNPX | Berger Mark Stanley | Chief Medical Officer | A | Common Stock | 245000 | $0.00 | 245,000.0000 | 0 | 9999.99% | 0.00% |